Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males

Nicotine and Tobacco Research

Volumn 5, Issue 2, 2003, Pages 195-203

  Haustein, Knut Olaf ^a   Krause, Jörn ^a   Haustein, Heidi ^a   Rasmussen, Thomas ^b   Cort, Nicholas ^b  

^a Inst of Nicotine Res/Smoking Cess   (Germany)

^b Pharmacia Consumer Healthcare   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; COTININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINE; NICOTINE GUM; OXYGEN; THIOCYANATE;

ABDOMINAL PAIN; ACCURACY; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG OVERDOSE; DRUG SAFETY; DYSPEPSIA; FLATULENCE; GASTROINTESTINAL TOXICITY; GENDER; HICCUP; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; OPEN STUDY; PRIORITY JOURNAL; RELAPSE; TRANSCUTANEOUS OXYGEN MONITORING; TREATMENT OUTCOME; VOMITING;

EID: 0038036820     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/146222003100073676     Document Type: Article

References (40)

1. Abou-Seif, M. A. (1996). Blood antioxidant status and urine sulfate and thiocyanate levels in smokers. Journal of Biochemical Toxicology, 11, 133-138.
2. Allen, S. S., Hatsukami, D., & Gorsline, J. (1994). Cholesterol changes in smoking cessation using the transdermal nicotine system. Transdermal Nicotine Study Group. Preventive Medicine, 23, 190-196.
3. Archbold, G. P., Cupples, M. E., McKnight, A., & Linton, T. (1995). Measurement of markers of tobacco smoking in patients with coronary heart disease. Annals of Clinical Biochemistry, 32 (Pt. 2), 201-207.
4. Benowitz, N. L. (1993). Nicotine replacement therapy. What has been accomplished - can we do better? Drugs, 45, 157-170.
5. Bohadana, A., Nilsson, F., Rasmussen, T., & Martinet, Y. (2000). Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: A randomized, double-blind, placebo-controlled trial. Archives of Internal Medicine, 160, 3128-3134.
6. Chambers, K. L., Ellard, G. A., Hewson, A. T., & Smith, R. F. (2001). Urine test for the assessment of smoking status. British Journal of Biomedical Science, 58, 61-65.
7. Cicco, G., Dolce, E., Vicenti, P., Stingi, G. D., Tarallo, M. S., & Pirrelli, A. (1999). Hemorheological aspects in hypertensive menopausal smoker women treated with female hormones. Clinical Hemorheology and Microcirculation, 21, 343-347.
8. de Maat, M. P., de Bart, A. C., Hennis, B. C., Meijer, P., Havelaar, A. C., Mulder, P. G., & Kluft, C. (1996). Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 1156-1162.
9. Eliasson, M., Asplund, K., Evrin, P. E., & Lundblad, D. (1995). Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis, 113, 41-53.
10. Fagerstrom, K. O., & Schneider, N. G. (1989). Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire. Journal of Behavioral Medicine, 12, 159-182.
11. Gupta, S. K., Hwang, S. S., Causey, D., Rolf, C. N., & Gorsline, J. (1995). Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking. Journal of Clinical Pharmacology, 35, 985-989.
12. Haustein, K. O. (1999). Smoking tobacco, microcirculatory changes and the role of nicotine. International Journal of Clinical Pharmacology and Therapeutics, 37, 76-85.
13. Haustein, K. O. (2000). Pharmacotherapy of nicotine dependence. International Journal of Clinical Pharmacology and Therapeutics, 38, 273-290.
14. Haustein, K. O., Krause, J., Haustein, H., Rasmussen, T., & Cort, N. (2002). Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. Journal of Internal Medicine 252, 130-139.
15. Hughes, J. R. (1996). Pharmacotherapy of nicotine dependence (pp. 599-626). In C. R. Schuster, & C. J. Kuhaz, (Eds.), Handbook of experimental pharmacology 118. Berlin: Springer-Verlag.
16. Hurt, R. D., Croghan, G. A., Wolter, T. D., Croghan, I. T., Offord, K. P., Williams, G. M., Djordjevic, M. V., Richie, J. P., Jr., & Jeffrey, A. M. (2000). Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine & Tobacco Research, 2, 327-336.
17. Jarvis, M. J., Goddard, E., Higgins, V., Feyerabend, C., Bryant, A., & Cook, D. G. (2000). Children's exposure to passive smoking in England since the 1980s: Cotinine evidence from population surveys. British Medical Journal, 321, 343-345.
18. Kiesewetter, H., Jung, F., Spitzer, S., Muller, G., & Wenzel, E. (1990). [The clinical rheological laboratory] Biomedizinische Technik. Biomedical Engineering, 35, 219-223.
19. Kornitzer, M., Boutsen, M., Dramaix, M., Thijs, J., & Gustavsson, G. (1995). Combined use of nicotine patch and gum in smoking cessation: A placebo-controlled clinical trial. Preventive Medicine, 24, 41-47.
20. Lowe, G. D., Drummond, M. M., Lorimer, A. R., Hutton, I., Forbes, C. D., Prentice, C. R., & Barbenel, J. C. (1980). Relation between extent of coronary artery disease and blood viscosity. British Medical Journal, 280, 673-674.
21. Mahmarian, J. J., Moye, L. A., Nasser, G. A., Nagueh, S. F., Bloom, M. F., Benowitz, N. L., Verani, M. S., Byrd, W. G., & Pratt, C. M. (1997). Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. Journal of the American College of Cardiology, 30, 125-130.
22. Mizuno, A., Uematsu, T., Ishikawa, T., Yoshimine, N., & Nakashima, M. (1997). Clinical outcome of smoking-cessation trial of nicotine chewing gum evaluated by analysis of nicotine in hair. Therapeutic Drug Monitoring, 19, 407-412.
23. Morabia, A., Bernstein, M. S., Curtin, F., & Berode, M. (2001). Validation of self-reported smoking status by simultaneous measurement of carbon monoxide and salivary thiocyanate. Preventive Medicine, 32, 82-88.
24. Nafstad, P., Kongerud, J., Botten, G., Urdal, P., Silsand, T., Pedersen, B. S., & Jaakkola, J. J. (1996). Fetal exposure to tobacco smoke products: A comparison between self-reported maternal smoking and concentrations of cotinine and thiocyanate in cord serum. Acta Obstetricia et Gynecologica Scandinavica, 75, 902-907.
25. Nafstad, P., Magnus, P., & Stray-Pedersen, B. (1995). Opposing placental gradients for thiocyanate and cotinine at birth. Early Human Development, 42, 73-79.
26. Owen, L., & McNeill, A. (2001). Saliva cotinine as indicator of cigarette smoking in pregnant women. Addiction, 96, 1001-1006.
27. Pichini, S., Basagana, X. B., Pacifici, R., Garcia, O., Puig, C., Vall, O., Harris, J., Zuccaro, P., Segura, J., & Sunyer, J. (2000). Cord serum cotinine as a biomarker of fetal exposure to cigarette smoke at the end of pregnancy. Environmental Health Perspectives, 108, 1079-1083.
28. Pirkle, J. L., Flegal, K. M., Bernert, J. T., Brody, D. J., Etzel, R. A., & Maurer, K. R. (1996). Exposure of the US population to environmental tobacco smoke: The Third National Health and Nutrition Examination Survey, 1988-1991. Journal of the American Medical Association, 275, 1233-1240.
29. Pollak, A., Marx, M., Salzer, H. R., Haster, F., Tenner, W., Podolsky, A., & Vytiska, E. (1988). [Plasma thiocyanate determination: A simple method for quantifying the smoking habits of pregnant patients - a preliminary study]. Wiener Klinische Wochenschrift, 100, 652-655.
30. Porozhanova, V., Tanchev, S., Bozhinova, S., & Angelova, M. (1997). [The plasma concentrations of thiocyanates, estradiol (E2), follicle-stimulating hormone (FSH) and prolactin (Prl) in women smokers]. Akusherstvo i Ginekooglia, 36, 9-11.
31. Puska, P., Korhonen, H. J., Vartiainen, E. U. E., & Gustavsson, G. W. A. (1995). Combined use of nicotine patch and gum compared with gum alone in smoking cessation: A clinical trial in North Carelia. Tobacco Control, 1, 243-252.
32. Quensel, M., Soderstrom, A., Agardh, C. D., & Nilsson-Ehle, P. (1989). High density lipoprotein concentrations after cessation of smoking: The importance of alterations in diet. Atherosclerosis, 75, 189-193.
33. Seersholm, N., Nielsen, N. H., & Tonnesen, P. (1999). Self-reported smoking habits, biochemical markers, and nicotine dependence in a sample of the Danish population. Journal of the Royal Society of Health, 119, 92-96.
34. Silagy, C., Lancaster, T., Stead, L., & Mant, D. F. G. (2001). Nicotine replacement therapy for smoking cessation (Cochrane review). (Updated Software, Issue 3). Oxford: The Cochrane Library.
35. Stubbe, I., Eskilsson, J., & Nilsson-Ehle, P. (1982). High-density lipoprotein concentrations increase after stopping smoking. British Medical Journal (Clinical Research Edition), 284, 1511-1513.
36. Tang, J. L., Law, M., & Wald, N. (1994). How effective is nicotine replacement therapy in helping people to stop smoking? British Medical Journal, 308, 21-26.
37. Urakawa, N., Nagata, T., Kudo, K., Kimura, K., & Imamura, T. (1994). Simultaneous determination of nicotine and cotinine in various human tissues using capillary gas chromatography/mass spectrometry. International Journal of Legal Medicine, 106, 232-236.
38. Wakefield, M., Banham, D., Martin, J., Ruffin, R., McCaul, K., & Badcock, N. (2000). Restrictions on smoking at home and urinary cotinine levels among children with asthma. American Journal of Preventive Medicine, 19, 188-192.
39. Wilkes, H. C., Kelleher, C., & Meade, T. W. (1988). Smoking and plasma fibrinogen. Lancet, 1, 307-308.
40. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. (1994). Nicotine replacement therapy for patients with coronary artery disease. Archives of Internal Medicine, 154, 989-995.